CLINICAL_TRIALS
trial_result
· 2015-10-29
Clinical Trial Update: Safety Study of Gleevec® in Children With Pulmonary Hypertension [Phase 2]
Summary
A Phase 2 safety study of imatinib (Gleevec) in children with pulmonary hypertension was terminated; results were posted in 2015.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indiana University | Conditions: Pulmonary Hypertension | Phase 2 | Status: TERMINATED | Results posted: 2015-10-29